| SC-Exos | Stem cell-derived exosomes |
| NPWT | Negative pressure wound therapy |
| MSCs | Mesenchymal stem cells |
| ECM | Extracellular matrix |
| PGDF | Platelet-derived growth factor |
| TGF-β | Transforming growth factor-β |
| VEGF | Vascular endothelial growth factor |
| FGF-2 | Fibroblast growth factor 2 |
| ADSCs | Adipose-derived stem cells |
| MMPs | Matrix metalloproteinases |
| TIMPs | Tissue inhibitors |
| MVBs | Multivesicular bodies |
| ILVs | Intraluminal vesicles |
| iPSCs | Pluripotent stem cells |
| BMMSCs | Bone marrow-derived mesenchymal stem cells |
| JMMSCs | Human jawbone marrow-derived mesenchymal stem cells |
| HUVECs | Human umbilical vein endothelial cells |
| iPSC-Exos | iPSC-derived exosomes |
| HucMSCs | Human umbilical cord MSCs |
| lncRNA | Long non-coding RNA |
| HF-MSC-Exos | Hair follicle mesenchymal stem cells |
| EV | Extracellular vesicles |
| TFF | Tangential flow filtration |
| GMP | Good Manufacturing Practice |